These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 30134903)

  • 21. Integrative analysis of epigenomics, transcriptomics, and proteomics to identify key targets and pathways of Weining granule for gastric cancer.
    Liang MK; Liang XQ; Zhong J; Wei YT; Lian ZP; Huang ZK; Liang J
    J Ethnopharmacol; 2021 Apr; 270():113787. PubMed ID: 33422657
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of Key Pathways and Genes in Anaplastic Thyroid Carcinoma via Integrated Bioinformatics Analysis.
    Hu S; Liao Y; Chen L
    Med Sci Monit; 2018 Sep; 24():6438-6448. PubMed ID: 30213925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction of novel target genes and pathways involved in bevacizumab-resistant colorectal cancer.
    Makondi PT; Lee CH; Huang CY; Chu CM; Chang YJ; Wei PL
    PLoS One; 2018; 13(1):e0189582. PubMed ID: 29342159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Paclitaxel reversed trastuzumab resistance via regulating JUN in human gastric cancer cells identified by FAN analysis.
    Wang Z; Zou F; Tian Y; Xiang B; Qin B; Liu Y
    Future Oncol; 2018 Nov; 14(26):2701-2712. PubMed ID: 30265158
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tetraspanin family identified as the central genes detected in gastric cancer using bioinformatics analysis.
    Qi W; Sun L; Liu N; Zhao S; Lv J; Qiu W
    Mol Med Rep; 2018 Oct; 18(4):3599-3610. PubMed ID: 30106120
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of prostate cancer hub genes and therapeutic agents using bioinformatics approach.
    Fang E; Zhang X; Wang Q; Wang D
    Cancer Biomark; 2017 Dec; 20(4):553-561. PubMed ID: 28800317
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of potential hub genes of gastric cancer.
    Zhou XD; Qu YW; Wang L; Jia FH; Chen P; Wang YP; Liu HF
    Medicine (Baltimore); 2022 Oct; 101(41):e30741. PubMed ID: 36254003
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gastric Cancer Cell Lines Have Different
    Maués JHDS; Ribeiro HF; Pinto GR; Lopes LO; Lamarão LM; Pessoa CMF; Moreira-Nunes CFA; de Carvalho RM; Assumpção PP; Rey JA; Burbano RMR
    Can J Gastroenterol Hepatol; 2018; 2018():5804376. PubMed ID: 30410872
    [No Abstract]   [Full Text] [Related]  

  • 29. Poor efficacy response to trastuzumab therapy in advanced gastric cancer with homogeneous HER2 positive and non-intestinal type.
    Xu C; Liu Y; Jiang D; Li Q; Ge X; Zhang Y; Huang J; Su J; Ji Y; Hou J; Lu S; Hou Y; Liu T
    Oncotarget; 2017 May; 8(20):33185-33196. PubMed ID: 28388541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
    Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
    Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of key candidate genes, pathways and related prognostic values in ER-negative/HER2-negative breast cancer by bioinformatics analysis.
    Shao N; Yuan K; Zhang Y; Yun Cheang T; Li J; Lin Y
    J BUON; 2018; 23(4):891-901. PubMed ID: 30358191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liquid biopsies to track trastuzumab resistance in metastatic HER2-positive gastric cancer.
    Wang DS; Liu ZX; Lu YX; Bao H; Wu X; Zeng ZL; Liu Z; Zhao Q; He CY; Lu JH; Wang ZQ; Qiu MZ; Wang F; Wang FH; Li YH; Wang XN; Xie D; Jia WH; Shao YW; Xu RH
    Gut; 2019 Jul; 68(7):1152-1161. PubMed ID: 30269082
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of Key Genes and Signaling Pathways Associated with the Progression of Gastric Cancer.
    Yu C; Chen J; Ma J; Zang L; Dong F; Sun J; Zheng M
    Pathol Oncol Res; 2020 Jul; 26(3):1903-1919. PubMed ID: 31848941
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Delineating the underlying molecular mechanisms and key genes involved in metastasis of colorectal cancer via bioinformatics analysis.
    Qi C; Chen Y; Zhou Y; Huang X; Li G; Zeng J; Ruan Z; Xie X; Zhang J
    Oncol Rep; 2018 May; 39(5):2297-2305. PubMed ID: 29517105
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of key pathways and genes in response to trastuzumab treatment in breast cancer using bioinformatics analysis.
    Zeng F; Fu J; Hu F; Tang Y; Fang X; Zeng F; Chu Y
    Oncotarget; 2018 Aug; 9(63):32149-32160. PubMed ID: 30181805
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognosis genes in gastric adenocarcinoma identified by cross talk genes in disease‑related pathways.
    Zhao L; Lei H; Shen L; Tang J; Wang Z; Bai W; Zhang F; Wang S; Li W
    Mol Med Rep; 2017 Aug; 16(2):1232-1240. PubMed ID: 28586067
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of key pathways and genes changes in pancreatic cancer cells (BXPC-3) after cross-talk with primary pancreatic stellate cells using bioinformatics analysis.
    Tang D; Wu Q; Yuan Z; Xu J; Zhang H; Jin Z; Zhang Q; Xu M; Wang Z; Dai Z; Fang H; Li Z; Lin C; Shi C; Xu M; Sun X; Wang D
    Neoplasma; 2019 Sep; 66(5):681-693. PubMed ID: 31169017
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bioinformatics Identification of Therapeutic Gene Targets for Gastric Cancer.
    Li Y; Chen M; Chen Q; Yuan M; Zeng X; Zeng Y; He M; Wang B; Han B
    Adv Ther; 2023 Apr; 40(4):1456-1473. PubMed ID: 36694099
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Collagen family genes and related genes might be associated with prognosis of patients with gastric cancer: an integrated bioinformatics analysis and experimental validation.
    Weng K; Huang Y; Deng H; Wang R; Luo S; Wu H; Chen J; Long M; Hao W
    Transl Cancer Res; 2020 Oct; 9(10):6246-6262. PubMed ID: 35117235
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification and characterization of biomarkers and their functions for docetaxel-resistant prostate cancer cells.
    Deng L; Gu X; Zeng T; Xu F; Dong Z; Liu C; Chao H
    Oncol Lett; 2019 Sep; 18(3):3236-3248. PubMed ID: 31452801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.